Hikal Limited

HIKALNSE · IN

Holders

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
1.2% of their portfolio
₹80.58 Cr
36,41,193 sh
as-of 31 Jul 2026T+30
Castilia Life Sciences Private Limited
Investor
₹6.04 Cr
6,04,63,828 sh
as-of 7 Aug 2026T+30

Ownership

FII holding ~flat QoQ

Jun 2026 quarter

Upgrade to see this quarter’s exact figures

Ownership by quarter

Promoter

— 0.0pp

Disclosure timeline

DISCLOSEDT+30
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Hikal Limited · NSE
36,41,193 sh · ₹80.58 Cr
Filed 31 Jul 2026AMFI portfolioview source
DISCLOSEDMonthly
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Hikal Limited · NSE
40,00,094 sh · ₹88.55 Cr
Filed 30 Jun 2026AMFI portfolioview source
DISCLOSEDStale
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Hikal Limited · NSE
40,00,094 sh · ₹78.11 Cr
Filed 31 May 2026AMFI portfolioview source
ACQUIREDStale
Castilia Life Sciences Private Limited
Hikal Limited · NSE
+3,02,31,914 sh · ₹6.04 Cr
Filed 18 Feb 2026SEBI Reg 7view source
ACQUIREDStale
Castilia Life Sciences Private Limited
Hikal Limited · NSE
+3,02,31,914 sh · ₹6.04 Cr
Filed 5 Dec 2025SEBI Reg 7view source
REDUCEDStale
Shri Rameshwara Investment Private Limited (RIPL)
Hikal Limited · NSE
−1,02,53,302 sh · ₹2.05 Cr
Filed 5 Dec 2025SEBI Reg 7view source
REDUCEDStale
Shri Badrinath Investment Private Limited (RIPL)
Hikal Limited · NSE
−1,99,78,612 sh · ₹4.00 Cr
Filed 5 Dec 2025SEBI Reg 7view source

Announcements

The announcements library is part of Pro.

Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.

20 announcements on record for this company.

Part of Pro — upgrade to open